SEC Tracker
Get the app

Tempest Therapeutics TPST

Tempest Therapeutics adjourns special meeting

Item 5.07 Shareholder vote results, Item 8.01 Other events

Form
8-K
Filed
Importance
Notable
  1. 74.3% of shares present at meeting
  2. Proposal requires 75% approval
  3. Meeting reconvened on Nov 12, 2026
  4. Proxies will be voted unless revoked

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Tempest Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. ProMIS Neurosciences PMN public float $30M, Jun 30, 2025
  2. Provectus Biopharmaceuticals PVCT public float $31M, Jun 30, 2025
  3. Cumberland Pharmaceuticals CPIX public float $29M, Jun 30, 2025
  4. Rockwell Medical RMTI public float $29M, Jun 30, 2025
  5. Champions Oncology CSBR public float $29M, Oct 31, 2025